{"schema_version":"1","generated_at":"2026-10-31T14:09:23.194Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jad-chahoud","json_url":"https://www.findmykol.com/kol/jad-chahoud/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jad-chahoud","name":"Jad Chahoud","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Orlando Health","institution_url":"https://www.findmykol.com/institution/orlando-health","city":"Orlando","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1164861167","orcid":"0000-0002-8435-0264","openalex":"A5014154182"},"summary":"Jad Chahoud is an Oncology physician affiliated with Orlando Health. OpenAlex indexes 286 publications with 2,706 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":286,"cited_by_count":2706,"h_index":30,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05579847","title":"Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy","status":"COMPLETED","role":"Overall official","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","source_url":"https://clinicaltrials.gov/study/NCT05579847","trial_url":"https://www.findmykol.com/trial/NCT05579847"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1164861167","source":"payments"},"prescribing":{"data_year":2023,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":65,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":49,"drugs":[{"name":"Inlyta","share_pct":44.9},{"name":"Everolimus","share_pct":30.6},{"name":"Lenvima","share_pct":24.5}],"max_beneficiaries":null},{"class":"Cytochrome P450 17A1 Inhibitor","setting":"prescribed","share_pct":16,"drugs":[{"name":"Abiraterone Acetate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":22,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":22,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":13,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":13,"drugs":[{"name":"Xarelto","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"The Prognostic Role of HPV or p16INK4a Status in Penile Squamous Cell Carcinoma: A Meta-Analysis","year":2025,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2024.7078","status":"verified"},{"title":"HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights","year":2024,"journal":"Pathogens","source_url":"https://doi.org/10.3390/pathogens13090809","status":"verified"},{"title":"15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis","year":2024,"journal":"EClinicalMedicine","source_url":"https://doi.org/10.1016/j.eclinm.2023.102413","status":"verified"},{"title":"Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironment","year":2024,"journal":"Genome biology","source_url":"https://doi.org/10.1186/s13059-024-03435-z","status":"verified"},{"title":"Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study","year":2024,"journal":"JNCI Journal of the National Cancer Institute","source_url":"https://doi.org/10.1093/jnci/djae034","status":"verified"}],"source":"works"},"similar":[{"name":"Eleftherios Mamounas","slug":"eleftherios-mamounas","institution":"Orlando Health","specialty":"Surgery","url":"https://www.findmykol.com/kol/eleftherios-mamounas","json_url":"https://www.findmykol.com/kol/eleftherios-mamounas/profile.json"},{"name":"Manoel Dos Passos Galvao Neto","slug":"manoel-dos-passos-galvao-neto","institution":"Orlando Health","specialty":"Surgery","url":"https://www.findmykol.com/kol/manoel-dos-passos-galvao-neto","json_url":"https://www.findmykol.com/kol/manoel-dos-passos-galvao-neto/profile.json"},{"name":"Karoly Horvath","slug":"karoly-horvath","institution":"Orlando Health","specialty":"Pediatric Gastroenterology","url":"https://www.findmykol.com/kol/karoly-horvath","json_url":"https://www.findmykol.com/kol/karoly-horvath/profile.json"},{"name":"Mohamed Elshazly","slug":"mohamed-elshazly","institution":"Orlando Health","specialty":"Clinical Cardiac Electrophysiology","url":"https://www.findmykol.com/kol/mohamed-elshazly","json_url":"https://www.findmykol.com/kol/mohamed-elshazly/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}